Comparison of mucus and serum biomarker sampling in chronic rhinosinusitis with nasal polyps
International Forum of Allergy & Rhinology · 2024
DOI: 10.1002/alr.23295 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Forum of Allergy & Rhinology, 2024. Verfasst von Sarina Katrin Mueller und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Hauptthemen laut MEDLINE: Biomarkers, Immunoglobulin E, Mucus, Nasal Polyps. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Merck, NINDS NIH HHS.
Abstract (Originalsprache)
Objective
The objective of this study was to analyze advantages and disadvantages of mucus and serum for biomarker analysis.
Methods
This study includes prospective study of 61 CRS with nasal polyps patients who were followed over 24 months and over nine time points after functional endoscopic sinus surgery. At each time points, the nasal polyp score (NPS) was assessed and mucus as well as serum was collected. Selected were measured in mucus and serum. Mean, standard deviation and variance, undetectable values, and the correlation of the biomarkers to the NPS over time and to early recurrences were calculated, and the effect of surgery on the biomarkers was assessed. Additionally, the diurnal rhythm of all biomarkers was measures in order to assure stable biomarker values during sampling times.
Results
All biomarkers showed stable values during sampling times. Serum biomarker levels displayed higher percentages of undetectable values compared to mucus biomarkers. Mucus periostin ( p < 0.001, r = 0.89), mucus IgE ( p < 0.001, r = 0.51), serum periostin ( p < 0.001, r = 0.53), mucus CST1 ( p < 0.001, r = 0.27), and serum IgE ( p < 0.01, r = −0.18) were the best marker and medium combinations to track the NPS over time and to predict recurrences. Mucus serpinF2 was negatively correlated and predicted early recurrences ( p = 0.026, R 2 = 0.015).
Conclusions
Serum and mucus both represent viable mediums for “liquid biopsies.” The most promising biomarker/medium combinations over time to track disease severity were mucus periostin, mucus IgE, serum periostin, mucus CST1, and serum IgE. Mucus serpinF2 was the best biomarker to predict early recurrences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
- Department of Otolaryngology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.
ORCID-Profile: Sarina Katrin Mueller, Benjamin S Bleier
Förderung
- Merck
- NINDS NIH HHS
Zitieren
APA
Mueller, S. K., Wendler, O., Mayr, S., Traxdorf, M., Koch, M., Mantsopoulos, K., Sievert, M., Grundtner, P., Iro, H., & Bleier, B. S. (2024). Comparison of mucus and serum biomarker sampling in chronic rhinosinusitis with nasal polyps. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23295
Vancouver
Mueller SK, Wendler O, Mayr S, Traxdorf M, Koch M, Mantsopoulos K, et al. Comparison of mucus and serum biomarker sampling in chronic rhinosinusitis with nasal polyps. International Forum of Allergy & Rhinology. 2024. doi:10.1002/alr.23295
BibTeX
@article{Mueller2024,
author = {Mueller, Sarina Katrin and Wendler, Olaf and Mayr, Susanne and Traxdorf, Maximilian and Koch, Michael and Mantsopoulos, Konstantinos and Sievert, Matti and Grundtner, Philipp and Iro, Heinrich and Bleier, Benjamin S},
title = {Comparison of mucus and serum biomarker sampling in chronic rhinosinusitis with nasal polyps},
journal = {International Forum of Allergy & Rhinology},
year = {2024},
doi = {10.1002/alr.23295}
}
EUVIMED